Cargando…

MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms

MALAT1 long non-coding RNA has oncogenic roles but has been poorly studied in indolent B-cell neoplasms. Here, MALAT1 expression was analyzed using RNA-seq, microarrays or qRT-PCR in primary samples from clinico-biological subtypes of chronic lymphocytic leukemia (CLL, n = 266), paired Richter trans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Garnacho, Elena María, Nadeu, Ferran, Martín, Silvia, Mozas, Pablo, Rivero, Andrea, Delgado, Julio, Giné, Eva, López-Guillermo, Armando, Duran-Ferrer, Martí, Salaverria, Itziar, López, Cristina, Beà, Sílvia, Demajo, Santiago, Jares, Pedro, Puente, Xose S., Martín-Subero, José Ignacio, Campo, Elías, Hernández, Lluís
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558466/ https://www.ncbi.nlm.nih.gov/pubmed/37803049 http://dx.doi.org/10.1038/s41598-023-44174-8

Ejemplares similares

Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma
por: Sureda-Gómez, Marta, et al.
Publicado: (2022)

RFcaller: a machine learning approach combined with read-level features to detect somatic mutations
por: Díaz-Navarro, Ander, et al.
Publicado: (2023)

All-CLL: A Capture-based Next-generation Sequencing Panel for the Molecular Characterization of Chronic Lymphocytic Leukemia
por: López-Oreja, Irene, et al.
Publicado: (2023)

P1295: DECIPHERING THE ROLE OF MSI2 AS A REGULATOR OF MANTLE CELL LYMPHOMA STEM-LIKE PROPERTIES
por: Sureda-Gómez, M., et al.
Publicado: (2022)

Epigenetic Activation of SOX11 in Lymphoid Neoplasms by Histone Modifications
por: Vegliante, Maria Carmela, et al.
Publicado: (2011)

PanCancer analysis of somatic mutations in repetitive regions reveals recurrent mutations in snRNA U2
por: Bousquets-Muñoz, Pablo, et al.
Publicado: (2022)

Check'-ing DLBCL
por: Salaverria, Itziar, et al.
Publicado: (2015)

Cell-Free DNA for Genomic Analysis in Primary Mediastinal Large B-Cell Lymphoma
por: Rivas-Delgado, Alfredo, et al.
Publicado: (2022)

Genetic Predisposition to Chronic Lymphocytic Leukemia Is Mediated by a BMF Super-Enhancer Polymorphism
por: Kandaswamy, Radhika, et al.
Publicado: (2016)

IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms
por: Nadeu, Ferran, et al.
Publicado: (2020)

Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience
por: Mozas, Pablo, et al.
Publicado: (2020)

Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
por: Giné, Eva, et al.
Publicado: (2022)

Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact
por: Mozas, Pablo, et al.
Publicado: (2020)

P600: DNA METHYLATION ANALYSIS OF B-CELL PROLYMPHOCYTIC LEUKEMIA REVEALS TWO EPIGENETIC SUBTYPES WITH DISTINCT BIOLOGICAL AND CLINICAL FEATURES
por: Charalampopoulou, Stella, et al.
Publicado: (2023)

Estimation of Copy Number Alterations from Exome Sequencing Data
por: Valdés-Mas, Rafael, et al.
Publicado: (2012)

mmsig: a fitting approach to accurately identify somatic mutational signatures in hematological malignancies
por: Rustad, Even H., et al.
Publicado: (2021)

Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma
por: Rosich, Laia, et al.
Publicado: (2014)

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia
por: Nadeu, F, et al.
Publicado: (2018)

Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints
por: Gonzalez-Farre, Blanca, et al.
Publicado: (2023)

Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics
por: Speedy, Helen E., et al.
Publicado: (2019)

ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution
por: Royo, Romina, et al.
Publicado: (2022)

Correction: ATM germline variants in a young adult with chronic lymphocytic leukemia: 8 years of genomic evolution
por: Royo, Romina, et al.
Publicado: (2022)

Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies
por: Delgado, Julio, et al.
Publicado: (2020)

Synergistic anti-tumor activity of acadesine (AICAR) in combination with the anti-CD20 monoclonal antibody rituximab in in vivo and in vitro models of mantle cell lymphoma
por: Montraveta, Arnau, et al.
Publicado: (2014)

Detection of chromothripsis‐like patterns with a custom array platform for chronic lymphocytic leukemia
por: Salaverria, Itziar, et al.
Publicado: (2015)

Mutations in the RAS-BRAF-MAPK-ERK pathway define a specific subgroup of patients with adverse clinical features and provide new therapeutic options in chronic lymphocytic leukemia
por: Giménez, Neus, et al.
Publicado: (2019)

Identification of Methylated Genes Associated with Aggressive Clinicopathological Features in Mantle Cell Lymphoma
por: Enjuanes, Anna, et al.
Publicado: (2011)

Role of Tyrosine Kinase Inhibitors in Indolent and Other Mature B-Cell Neoplasms
por: Kutsch, Nadine, et al.
Publicado: (2015)

Author Correction: A practical guide for mutational signature analysis in hematological malignancies
por: Maura, Francesco, et al.
Publicado: (2019)

A practical guide for mutational signature analysis in hematological malignancies
por: Maura, Francesco, et al.
Publicado: (2019)

Unraveling the genetics of transformed splenic marginal zone lymphoma
por: Grau, Marta, et al.
Publicado: (2023)

Chronic lymphocytic leukemia and prolymphocytic leukemia. Two coins or two sides of the same coin?
por: Magnano, Laura, et al.
Publicado: (2020)

ENDOG Impacts on Tumor Cell Proliferation and Tumor Prognosis in the Context of PI3K/PTEN Pathway Status
por: Barés, Gisel, et al.
Publicado: (2021)

Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma
por: Gonzalez-Farre, Blanca, et al.
Publicado: (2019)

P1337: IDENTIFICATION OF CLONAL HEMATOPOIESIS DRIVER MUTATIONS THROUGH IN SILICO SATURATION MUTAGENESIS
por: Demajo, Santiago, et al.
Publicado: (2023)

Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review
por: Rivero, Andrea, et al.
Publicado: (2023)

The genomic landscape of chronic lymphocytic leukemia: clinical implications
por: Quesada, Víctor, et al.
Publicado: (2013)

A novel patient-derived 3D model recapitulates mantle cell lymphoma lymph node signaling, immune profile and in vivo ibrutinib responses
por: Araujo-Ayala, Ferran, et al.
Publicado: (2023)

P608: THE EXPRESSION OF CYTOR LNCRNA HAS POOR PROGNOSTIC VALUE IN CLL PATIENTS AND IS ASSOCIATED WITH MICROENVIRONMENTAL STIMULI.
por: Hernández, Lluís, et al.
Publicado: (2023)

Solid Pseudopapillary Neoplasms Are Rare, Indolent Pancreatic Tumors in Young Women
por: Dalili, Amin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_iif1mhnn1mbdejqml15pmqrb4r